Detalles de la búsqueda
1.
Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice.
Int J Mol Sci
; 25(7)2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612688
2.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Future Oncol
; 18(7): 771-779, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35068173
3.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
4.
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
Br J Cancer
; 119(11): 1326-1331, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30405211
5.
Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.
Gastric Cancer
; 17(4): 711-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24282019
6.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489861
7.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer
; 25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
8.
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres.
Life (Basel)
; 12(8)2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36013328
9.
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.
J Transl Med
; 9: 179, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22013950
10.
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.
Tumori
; 96(1): 48-53, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20437857
11.
Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
J Immunother
; 43(1): 1-7, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31574022
12.
Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 12(3)2020 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32120803
13.
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases.
Front Oncol
; 10: 588862, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33282740
14.
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients.
J Thorac Oncol
; 15(1): 80-90, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31622732
15.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Lung Cancer
; 150: 123-131, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33130353
16.
Patient performance status and cancer immunotherapy efficacy: a meta-analysis.
Med Oncol
; 35(10): 132, 2018 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30128793
17.
Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
PLoS One
; 13(7): e0201425, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30052658
18.
Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
Clin Lung Cancer
; 19(4): 315-322, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29530732
19.
A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer.
Tumori
; 93(3): 244-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17679458
20.
Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?
Eur J Cancer
; 79: 149-151, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28494405